vimarsana.com

Global Access Programto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

F Hoffmann-La Roche Ltd: Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries

Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women

United statesLoren kalmSabine borngrKirti pandeyGerard tobinNathalie altermattBirgit masjostBruno eschliMatt sauseRoche group media relationsRoche groupWorld health organizationGlobal access programRoche global access programHuman papillomavirusGlobal access

vimarsana © 2020. All Rights Reserved.